Sulforaphane for Autism Spectrum Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether sulforaphane, a compound found in some vegetables, can improve understanding of autism spectrum disorder. Researchers aim to determine if digital tools, such as wearable devices that track heart rate and movement, can complement traditional assessment methods. Participants will take a sulforaphane pill once daily for 12 weeks. The trial seeks males aged 13 to 30 who have been diagnosed with autistic disorder and participated in a previous related study. As an unphased trial, it offers participants the chance to contribute to groundbreaking research that could enhance understanding and treatment of autism spectrum disorder.
Do I need to stop my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if you are currently taking antibiotics or have a chronic medical disorder, you may not be eligible to participate.
Is there any evidence suggesting that sulforaphane is likely to be safe for humans?
Research has shown that sulforaphane, a substance in broccoli, is generally safe for people. Studies have found that products high in sulforaphane can be used safely for up to six months. Specifically, when used to help treat autism spectrum disorder (ASD), sulforaphane has very few side effects.
Participants in previous trials reported that the treatment was easy to handle, with only a few mild side effects. These results suggest that sulforaphane could be a safe choice for those considering joining a clinical trial for ASD treatment.12345Why are researchers excited about this trial?
Most treatments for Autism Spectrum Disorder, like behavioral therapies and medications, aim to manage symptoms rather than address underlying biological factors. Sulforaphane is unique because it's derived from cruciferous vegetables like broccoli and works by targeting oxidative stress and inflammation, which are thought to play a role in autism. Researchers are excited about sulforaphane because it offers a natural and potentially safer option that tackles these biological aspects, potentially improving core symptoms of autism. This treatment's novel mechanism could make it a valuable addition to existing therapeutic strategies.
What evidence suggests that sulforaphane might be an effective treatment for autism?
Research has shown that sulforaphane, a substance found in some vegetables, may help treat autism spectrum disorder (ASD). Studies have found that taking sulforaphane led to noticeable improvements in behavior. For instance, one study reported a 34% improvement in behaviors among young men with ASD. Another study noted that sulforaphane helped reduce symptoms like irritability and hyperactivity. Importantly, these benefits came with very few side effects, making sulforaphane a safe option to consider. Overall, the evidence suggests that sulforaphane could be an effective treatment for ASD. Participants in this trial will receive sulforaphane to further evaluate its effectiveness and safety.46789
Are You a Good Fit for This Trial?
This trial is for males aged 13-30 with a diagnosis of autistic disorder who previously participated in clinical trial NCT02677051. It's not for those using broccoli extracts post-trial, without guardian consent, unable to commit to the study schedule, or with recent seizures, kidney/liver/thyroid disease, infections, antibiotics use, or major surgery within 3 months.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 1.47umol/kg/day sulforaphane for 12 weeks. Digital biomarkers are measured using non-invasive devices.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with primary outcome measures assessed at Week 16.
What Are the Treatments Tested in This Trial?
Interventions
- Sulforaphane
Sulforaphane is already approved in United States for the following indications:
- None approved; used in clinical trials for various conditions including chronic kidney disease and prevention of age-associated cardiac and vascular dysfunction
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor